Literature DB >> 16902784

Mechanisms of development and progression of cyanotic nephropathy.

Jun Inatomi1, Kentaro Matsuoka, Rika Fujimaru, Atsuko Nakagawa, Kazumoto Iijima.   

Abstract

Cyanotic nephropathy (CN) is often accompanied by congenital cyanotic heart diseases (CCHD). The purpose of this study was to clarify the risk factors and the mechanisms of involved in the development and progression of CN. Thirty patients with CCHD were examined. We analyzed the risk factors for the development of CN on the basis of the clinical and laboratory findings. We also examined ten renal biopsy specimens obtained from patients with CN. Patients with CN showed significantly higher hematocrit levels than those without CN (P=0.025), although there was no difference between the two groups in terms of oxygen saturation. The renal plasma flow (RPF) in patients both with and without CN was low. However, the filtration fraction (FF) was significantly lower in patients with CN than in those without CN (P=0.001). The glomeruli of biopsy specimens with significant proteinuria (n=7) were larger than those of biopsy specimens without significant proteinuria, and there were more capillaries per glomerulus in the former than in the latter (n=3) and the control specimens (n=6) (glomerular size: P<0.01; number of glomerular capillaries: P<0.01). In conclusion, hyperviscosity by polycythemia may be responsible for the development of CN. This pathological condition may induce an angiogenic increase in the glomerular capillary beds, in turn leading to glomerulomegaly. In addition, the failure of a compensatory mechanism to respond to reduced RPF by hyperfiltration may be accompanied by the development and progression of CN.

Entities:  

Mesh:

Year:  2006        PMID: 16902784     DOI: 10.1007/s00467-006-0220-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor.

Authors:  Kazuyuki Hida; Jun Wada; Hiroko Yamasaki; Yoshio Nagake; Hong Zhang; Hitoshi Sugiyama; Kenichi Shikata; Hirofumi Makino
Journal:  Nephrol Dial Transplant       Date:  2002-01       Impact factor: 5.992

2.  Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease.

Authors:  J K Perloff; H Latta; P Barsotti
Journal:  Am J Cardiol       Date:  2000-12-01       Impact factor: 2.778

Review 3.  THE GLOMERULUS IN CYANOTIC CONGENITAL HEART DISEASE AND PRIMARY PULMONARY HYPERTENSION. A REVIEW.

Authors:  G S SPEAR
Journal:  Nephron       Date:  1964       Impact factor: 2.847

4.  Glomerular alterations in cyanotic congenital heart disease.

Authors:  G S SPEAR
Journal:  Bull Johns Hopkins Hosp       Date:  1960-06

5.  Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis.

Authors:  M Nagata; W Kriz
Journal:  Kidney Int       Date:  1992-07       Impact factor: 10.612

6.  Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.

Authors:  J W Fries; D J Sandstrom; T W Meyer; H G Rennke
Journal:  Lab Invest       Date:  1989-02       Impact factor: 5.662

7.  Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis.

Authors:  A Fogo; E P Hawkins; P L Berry; A D Glick; M L Chiang; R C MacDonell; I Ichikawa
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

8.  Renal involvement in patients with congenital cyanotic heart disease.

Authors:  F Krull; J H Ehrich; U Wurster; U Toel; S Rothgänger; I Luhmer
Journal:  Acta Paediatr Scand       Date:  1991-12

9.  Renal impairment in patients with long-standing cyanotic congenital heart disease.

Authors:  S Dittrich; N A Haas; C Bührer; C Müller; I Dähnert; P E Lange
Journal:  Acta Paediatr       Date:  1998-09       Impact factor: 2.299

10.  Nitric oxide mediates renal vasodilation during erythropoietin-induced polycythemia.

Authors:  C S Wilcox; X Deng; A H Doll; H Snellen; W J Welch
Journal:  Kidney Int       Date:  1993-08       Impact factor: 10.612

View more
  17 in total

Review 1.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

2.  Is it time for a multi-specialty approach to cardio-renal dysfunction in children with cyanotic congenital heart disease?

Authors:  Tanya Holt; Guido Filler
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

Review 3.  Epidemiology and outcome of the cardio-renal syndrome.

Authors:  Dinna N Cruz; Mihai Gheorghiade; Alberto Palazzuoli; Alberto Palazuolli; Claudio Ronco; Sean M Bagshaw
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

4.  Repeated phlebotomies improve and stabilise renal function in cyanotic nephropathy.

Authors:  Kennedy O Omonuwa; Arunabh Talwar; Sophy Dedopoulos; Lionel U Mailloux
Journal:  BMJ Case Rep       Date:  2009-03-20

5.  Successful initiation and maintenance of hemodialysis in an adult patient with complete transposition of the great arteries.

Authors:  Shunsuke Yamada; Hideki Yotsueda; Masatomo Taniguchi; Kazuhiko Tsuruya; Hideki Hirakata; Mitsuo Iida
Journal:  Clin Exp Nephrol       Date:  2010-07-06       Impact factor: 2.801

6.  Critical care management of the adult patient with congenital heart disease: focus on postoperative management and outcomes.

Authors:  Nathalie Roy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-02

7.  Renal function and injury in infants and young children with congenital heart disease.

Authors:  Jianyong Zheng; Yong Yao; Ling Han; Yanyan Xiao
Journal:  Pediatr Nephrol       Date:  2012-08-25       Impact factor: 3.714

8.  Baseline tubular biomarkers in young adults with congenital heart disease as compared to healthy young adults: Detecting subclinical kidney injury.

Authors:  Dana Y Fuhrman; Lan Nguyen; Morgan Hindes; John A Kellum
Journal:  Congenit Heart Dis       Date:  2019-12-02       Impact factor: 2.007

9.  Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.

Authors:  Nattaphorn Hongsawong; Prapimdaw Khamdee; Suchaya Silvilairat; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

10.  Heart-kidney interaction: epidemiology of cardiorenal syndromes.

Authors:  Dinna N Cruz; Sean M Bagshaw
Journal:  Int J Nephrol       Date:  2010-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.